Elen Höglander

436 total citations
5 papers, 32 citations indexed

About

Elen Höglander is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elen Höglander has authored 5 papers receiving a total of 32 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elen Höglander's work include Cancer Genomics and Diagnostics (3 papers), Cancer Diagnosis and Treatment (2 papers) and Medical Imaging and Pathology Studies (1 paper). Elen Höglander is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Cancer Diagnosis and Treatment (2 papers) and Medical Imaging and Pathology Studies (1 paper). Elen Höglander collaborates with scholars based in United Kingdom, Spain and Switzerland. Elen Höglander's co-authors include Anne‐Marie C. Dingemans, Marit Krohn, Thomas Fleischer, Peter Van Loo, Bjørn Naume, Marit Muri Holmen, Vessela N. Kristensen, Frank Griesinger, Øystein Garred and Luis Paz‐Ares and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Elen Höglander

4 papers receiving 32 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elen Höglander United Kingdom	4	19	13	10	9	6	5	32
Jakob Sidenius Johansen Denmark	4	14 0.7×	19 1.5×	12 1.2×	18 2.0×	8 1.3×	10	43
Briana M. Hudson United States	3	22 1.2×	12 0.9×	10 1.0×	12 1.3×	8 1.3×	3	34
Rajesh Gottimukkala United States	2	14 0.7×	11 0.8×	7 0.7×	12 1.3×	3 0.5×	4	28
Guowu Wu China	3	14 0.7×	13 1.0×	8 0.8×	5 0.6×	4 0.7×	8	26
Ross Wallace United States	3	15 0.8×	11 0.8×	15 1.5×	10 1.1×	12 2.0×	9	30
Beatriz Rojas Spain	3	18 0.9×	5 0.4×	7 0.7×	11 1.2×	3 0.5×	7	30
Nuntana Dinglasan United States	2	19 1.0×	19 1.5×	7 0.7×	8 0.9×	5 0.8×	5	35
Jad Alshami Canada	3	9 0.5×	11 0.8×	8 0.8×	6 0.7×	4 0.7×	4	29
Hendrick-Tobias Arkenau United Kingdom	4	23 1.2×	20 1.5×	17 1.7×	5 0.6×	4 0.7×	6	41
Shivam Mathura United States	3	24 1.3×	9 0.7×	8 0.8×	16 1.8×	13 2.2×	5	30

Countries citing papers authored by Elen Höglander

Since Specialization

Citations

This map shows the geographic impact of Elen Höglander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elen Höglander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elen Höglander more than expected).

Fields of papers citing papers by Elen Höglander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elen Höglander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elen Höglander. The network helps show where Elen Höglander may publish in the future.

Co-authorship network of co-authors of Elen Höglander

This figure shows the co-authorship network connecting the top 25 collaborators of Elen Höglander. A scholar is included among the top collaborators of Elen Höglander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elen Höglander. Elen Höglander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Westphalen, C. Benedikt, Chantal Pauli, Nasséra Chalabi, et al.. (2023). Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study. ESMO Open. 8(6). 102035–102035. 7 indexed citations

2.

Ardizzoni, Andrea, Sérgio Jobim Azevedo, Belén Rubio‐Viqueira, et al.. (2022). Final results from TAIL: updated long-term efficacy of atezolizumab in a diverse population of patients with previously treated advanced non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 10(11). e005581–e005581. 3 indexed citations

3.

Dingemans, Anne‐Marie C., Frank Griesinger, Luis Paz‐Ares, et al.. (2022). A randomized phase 3 study of entrectinib versus crizotinib in patients (pts) with locally advanced/metastatic ROS1 fusion-positive (fp) NSCLC with or without baseline CNS metastases (mets).. Journal of Clinical Oncology. 40(16_suppl). TPS9141–TPS9141. 4 indexed citations

4.

Westphalen, C. Benedikt, Andreas Beringer, Tilmann Bochtler, et al.. (2021). 1804P Baseline mutational profiles of patients (pts) with carcinoma-of-unknown-primary-origin (CUP) enrolled onto CUPISCO. Annals of Oncology. 32. S1227–S1228.

5.

Höglander, Elen, Silje Nord, David C. Wedge, et al.. (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine. 10(1). 92–92. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact